Robert W Duggan - Net Worth and Insider Trading
Robert W Duggan Net Worth
The estimated net worth of Robert W Duggan is at least $11.5 Billion dollars as of 2024-12-27. Robert W Duggan is the CEO of Summit Therapeutics Inc and owns about 552,354,161 shares of Summit Therapeutics Inc (SMMT) stock worth over $10.6 Billion. Robert W Duggan is the Director, 10% Owner of Pulse Biosciences Inc and owns about 43,290,683 shares of Pulse Biosciences Inc (PLSE) stock worth over $811 Million. Robert W Duggan is also the 10% Owner of Achaogen Inc and owns about 5,757,839 shares of Achaogen Inc (AKAOQ) stock worth over $143,946. Besides these, Robert W Duggan also holds Intuitive Surgical Inc (ISRG) . Details can be seen in Robert W Duggan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert W Duggan has not made any transactions after 2024-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert W Duggan
Robert W Duggan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert W Duggan owns 4 companies in total, including Summit Therapeutics Inc (SMMT) , Pulse Biosciences Inc (PLSE) , and Achaogen Inc (AKAOQ) among others .
Click here to see the complete history of Robert W Duggan’s form 4 insider trades.
Insider Ownership Summary of Robert W Duggan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SMMT | Summit Therapeutics Inc | 2023-03-06 | director & 10 percent owner & See Remarks |
| PLSE | Pulse Biosciences Inc | 2024-12-13 | director & 10 percent owner |
| AKAOQ | Achaogen Inc | 2019-03-20 | 10 percent owner |
 | | 2011-05-03 | director |
Robert W Duggan Latest Holdings Summary
Robert W Duggan currently owns a total of 4 stocks. Among these stocks, Robert W Duggan owns 552,354,161 shares of Summit Therapeutics Inc (SMMT) as of March 6, 2023, with a value of $10.6 Billion and a weighting of 92.92%. Robert W Duggan owns 43,290,683 shares of Pulse Biosciences Inc (PLSE) as of December 13, 2024, with a value of $811 Million and a weighting of 7.08%. Robert W Duggan also owns 5,757,839 shares of Achaogen Inc (AKAOQ) as of March 20, 2019, with a value of $143,946 and a weighting of 0%. The other 1 stocks Intuitive Surgical Inc (ISRG) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Robert W Duggan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc | 2023-03-06 | 552,354,161 | 19.28 | 10,649,388,224 |
| PLSE | Pulse Biosciences Inc | 2024-12-13 | 43,290,683 | 18.73 | 810,834,493 |
| AKAOQ | Achaogen Inc | 2019-03-20 | 5,757,839 | 0.03 | 143,946 |
| ISRG | Intuitive Surgical Inc | 2011-05-03 | 0 | 538.83 | 0 |
Holding Weightings of Robert W Duggan
Robert W Duggan Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert W Duggan has made a total of 3 transactions in Summit Therapeutics Inc (SMMT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Summit Therapeutics Inc is the acquisition of 376,489,880 shares on March 6, 2023, which cost Robert W Duggan around $395 Million.
According to the SEC Form 4 filings, Robert W Duggan has made a total of 16 transactions in Pulse Biosciences Inc (PLSE) over the past 5 years, including 16 buys and 0 sells. The most-recent trade in Pulse Biosciences Inc is the acquisition of 55,256 shares on December 13, 2024, which cost Robert W Duggan around $949,298.
According to the SEC Form 4 filings, Robert W Duggan has made a total of 0 transactions in Achaogen Inc (AKAOQ) over the past 5 years. The most-recent trade in Achaogen Inc is the sale of 1,277,888 shares on March 20, 2019, which brought Robert W Duggan around $690,060.
More details on Robert W Duggan's insider transactions can be found in the Insider Trading History of Robert W Duggan table.Insider Trading History of Robert W Duggan
- 1
Robert W Duggan Trading Performance
GuruFocus tracks the stock performance after each of Robert W Duggan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert W Duggan is 6.83%. GuruFocus also compares Robert W Duggan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert W Duggan within 3 months outperforms 23 times out of 47 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert W Duggan's insider trading performs compared to the benchmark.
Performance of Robert W Duggan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.67 | | | | | |
| Relative Return to S&P 500(%) | 10.76 | | | | | |
Robert W Duggan Ownership Network
Robert W Duggan Owned Company Details
What does Summit Therapeutics Inc do?
Who are the key executives at Summit Therapeutics Inc?
Robert W Duggan is the director & 10 percent owner & See Remarks of Summit Therapeutics Inc. Other key executives at Summit Therapeutics Inc include Chief Financial Officer Ankur Dhingra , VP & Corporate Controller Jeffrey R Maranian , and Chief Scientific Officer David Jonathan Powell .
Summit Therapeutics Inc (SMMT) Insider Trades Summary
Over the past 18 months, Robert W Duggan made no insider transaction in Summit Therapeutics Inc (SMMT). Other recent insider transactions involving Summit Therapeutics Inc (SMMT) include a net purchase of 120,400 shares made by Ankur Dhingra , a net purchase of 115,321 shares made by Maky Zanganeh , and a net purchase of 2,976,190 shares made by Manmeet Singh Soni .
In summary, during the past 3 months, insiders sold 0 shares of Summit Therapeutics Inc (SMMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Summit Therapeutics Inc (SMMT) were sold and 3,211,911 shares were bought by its insiders, resulting in a net purchase of 3,211,911 shares.
Summit Therapeutics Inc (SMMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Summit Therapeutics Inc Insider Transactions
Robert W Duggan Mailing Address
Above is the net worth, insider trading, and ownership report for Robert W Duggan. You might contact Robert W Duggan via mailing address: 611 South Fort Harrison Ave, Suite 306, Clearwater Fl 33756.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
